[Insert Logo]

Applying Guideline-Directed Care for Patients With T2D: Focus on Glucagon-Like Peptide-1 Receptor Agonists

Speakers:  Kathleen Dungan, MD, MPH; Jay Schubrook, DO, FACOFP

OBJECTIVES:

 Explain how glucagon-like peptide-1 receptor agonists (GLP-1 RAs) function in treating type 2 diabetes (T2D) and their extra-glycemic effects

 Examine safety considerations related to GLP-1 RAs and explore effective approaches for addressing adverse events associated with their use

 Evaluate the guidance for comprehensive approaches to care and early management of T2D

Expiration Date: November 5, 2027

The AOA designates this activity for a maximum of 1.5 AOA Category 1-A Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This educational activity is supported by an independent educational grant from Novo Nordisk, Inc.